Protein tyrosine Phosphatase (PTP1B): A promising Drug Target against life threatening ailments.
Protein tyrosine phosphatases are enzymes which help in signal transduction in diabetes, obesity, cancer, liver diseases and neurodegenerative diseases. PTP1B is the main member of this enzyme from the protein extract of human placenta. In phosphate inhibitors development significant progress has been made over the last 10 years, few compounds has reached in early-stage clinical trials whereas later stage trials or registration yet none have progressed. Many researchers are investigating different ways to improve the pharmacological properties of PTP1B inhibitors. In the present review, authors have summarized various aspects related to involvement of PTP1B in various types of signal transduction mechanisms and its prominent role in various diseases like cancer, liver diseases and diabetes mellitus. There are still certain challenges for selection of PTP1B as a drug target. Therefore continuous future efforts are needed to explore this target for development of PTP inhibitors to treat the prevailing diseases associated with it.